Your browser doesn't support javascript.
loading
Outpatient Extraperitoneal Single-Port Robotic Radical Prostatectomy.
Wilson, Clark A; Aminsharifi, Alireza; Sawczyn, Guilherme; Garisto, Juan D; Yau, Roger; Eltemamy, Mohamed; Kim, Soodong; Lenfant, Louis; Kaouk, Jihad.
Affiliation
  • Wilson CA; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Aminsharifi A; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH; Department of Urology, Shiraz University of Medical Sciences, Shiraz, Iran.
  • Sawczyn G; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Garisto JD; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Yau R; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Eltemamy M; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Kim S; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH.
  • Lenfant L; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH; Sorbonne University, GRC n°5, PREDICTIVE ONCO-UROLOGY, AP-HP, Pitié-Salpêtrière Hospital, F-75013 Paris, France.
  • Kaouk J; Glickman Urology and Kidney Institute, Cleveland Clinic, Cleveland, OH. Electronic address: kaoukj@ccf.org.
Urology ; 144: 142-146, 2020 10.
Article in En | MEDLINE | ID: mdl-32619598
ABSTRACT

OBJECTIVE:

To assess the safety and feasibility of extraperitoneal single-port robotic assisted laparoscopic radical prostatectomy using the da Vinci SP robotic platform for same-day surgery.

METHODS:

Extraperitoneal single-port robotic prostatectomy (ESRP) using the da Vinci SP platform was performed on 60 patients with clinically localized prostate cancer and no prior definitive therapy. An enhanced recovery protocol was used in the perioperative period and minimal to no opiates were used in these patients. Preoperative, perioperative, and postoperative data were collected in a prospectively maintained institutional review board approved database and evaluated in a retrospective fashion.

RESULTS:

Mean operative time was 198 minutes and mean estimated blood loss was 179 mL. No patients required blood transfusion and there were no intraoperative complications. Pain at discharge was 0-1 in 37% of patients. Forty-five patients (75%) were discharged home the day of surgery, including patients with all surgical start times. When excluding patients that were planned for an overnight stay preoperatively or patients whose surgery finished after 6 PM, 88% of patients were discharged home the day of surgery and 96% were discharged within 24 hours of surgery. Median length of stay was 4.2 hours. Fourty-eight percent of patients required 0-1 pads at 30 days postoperatively in patients with 30 day follow data (n = 58) and 76% of patients reported requiring 0-1 pads per day by 90 days postoperatively (n = 37).

CONCLUSION:

ESRP using the da Vinci SP platform can be performed safely and reproducibly as a same-day outpatient surgery with minimal to no opiate use, excellent pain control, and acceptable short term functional and oncological outcomes.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain, Postoperative / Prostatectomy / Prostatic Neoplasms / Robotic Surgical Procedures / Ambulatory Surgical Procedures Type of study: Etiology_studies / Guideline / Observational_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Urology Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pain, Postoperative / Prostatectomy / Prostatic Neoplasms / Robotic Surgical Procedures / Ambulatory Surgical Procedures Type of study: Etiology_studies / Guideline / Observational_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Urology Year: 2020 Document type: Article